Irregular periods, acne, excess facial hair, disturbed mood, or a fear of not conceiving- does this sound familiar? If you or anyone related to you has experienced at least a few of these symptoms, if not all, then you deserve to know what’s happening to your body, and this guide has you covered.
You have probably heard of PCOS, the most common endocrine disorder of menstruating women. In May 2026, polycystic ovary syndrome (PCOS) was renamed as polyendocrine metabolic ovarian syndrome (PMOS), keeping in mind its endocrine nature.12 It was finally found and admitted that PMOS was never only a period problem. Three things drive PMOS and feed one another: higher-than-usual androgens (hormones like testosterone), insulin resistance (your body making extra insulin to keep blood sugar normal), and ovaries that struggle to release an egg on schedule.13 That is why one condition shows up as missed periods, jawline acne, unwanted hair growth, thinning hair, low mood, poor sleep, and trouble conceiving; often all at once. Two myths need clearing up. PMOS does not mean you cannot get pregnant; most women who want a baby will have one.4 And it is not a “weight problem”; it affects women of every body size.3
On this page
- What is PMOS?
- What does PMOS stand for?
- Is PMOS hormonal, metabolic, or reproductive?
- What causes PMOS?
- What are the risk factors for PMOS?
- Can you develop PMOS at a normal weight (lean PMOS)?
- What are the signs and symptoms of PMOS?
- PMOS through the lifespan
- How is PMOS diagnosed?
- What is the role of serum AMH and an ultrasound in PMOS?
- What are the complications and long-term risks of PMOS?
- How helpful is lifestyle and self-care?
- What are the medical treatments for PMOS?
- What are the new treatments for PMOS?
- How can you manage your symptoms day-to-day?
- Can PMOS be prevented?
- What is living with PMOS like?
- What should you ask your doctor?
- When to see a doctor?
Key takeaways
- PMOS is the new name for PCOS, reflecting its hormonal, metabolic, ovarian, and reproductive effects.
- The 2026 name change did not change the diagnostic criteria; diagnosis still follows the established 2023 guideline framework.
- PMOS can affect women of any body size, including those with normal weight.
- Diagnosis is based on a combination of ovulatory dysfunction, hyperandrogenism, and/or polycystic ovarian morphology, after excluding other conditions.
- PMOS can affect metabolic, cardiovascular, reproductive, skin, sleep, and mental health.
- Lifestyle management is an important part of treatment, and exercise can improve insulin sensitivity even without weight loss.
- Treatment should be individualized according to the patient’s goals, such as cycle regulation, metabolic health, acne/hirsutism, or fertility.
- PMOS does not mean infertility; many women can conceive naturally, while medications such as letrozole can help when ovulation induction is needed.
- PMOS is a long-term condition, so metabolic and cardiovascular health should continue to be monitored beyond the reproductive years.
- Women with persistent irregular periods, worsening androgen-related symptoms, fertility difficulties, or concerning metabolic symptoms should seek medical evaluation.
What is PMOS?
In 1935, American physicians Irving Stein and Michael Leventhal described women with absent periods, excess hair growth, and enlarged, speckled-looking ovaries. It became Stein-Leventhal syndrome, and later “polycystic ovary syndrome”, named for the ovaries’ appearance, the most visible clue at the time.
What does PMOS stand for?
The 2026 name breaks into four parts15:
- Poly-endocrine: More than one hormone system is involved.
- Metabolic: It affects how your body handles blood sugar, insulin, and fats.
- Ovarian: The ovaries are involved, particularly in how often you ovulate.
- Syndrome: Related signs and symptoms that occur together, rather than a single disease with a single cause.
Is PMOS hormonal, metabolic, or reproductive?
It has all three elements, and they are interconnected. Higher insulin pushes the ovaries to make more androgens (male sex hormones); higher androgens make it harder for a follicle to mature and release an egg, and missed ovulation means less progesterone, which alters the signals sent back to the brain, pushing the ovaries harder still. Because the loop has no clear starting point, treating one part rarely fixes everything.
What does “polycystic” actually mean?
The most misunderstood word in the old name. The “cysts” on ultrasound are not true cysts; rather, they are normal, immature egg sacs called antral follicles that every ovary contains. In PMOS, more of them than usual stall partway through development instead of one growing large and releasing an egg. They are not dangerous, do not need draining or removal, and are not the painful ovarian cysts you may have heard of. Correcting this misnomer was a major reason for the name change.12
How common is PMOS?
PMOS affects roughly 1 in 8 women worldwide, more than 170 million people.2 Estimates range from 5% to 15% of women of reproductive age depending on criteria and population.47 It is badly underdiagnosed: up to 70% of affected women do not know they have it.8
Who can develop PMOS?
PMOS affects teenagers, women in their twenties and thirties, women at a normal weight (“lean PMOS”), women with overweight or obesity, and women in perimenopause and beyond. Most are diagnosed in their twenties or thirties, often when seeing a doctor about irregular periods or difficulty conceiving.4
PMOS can also look a little different depending on your background. The metabolic side, like insulin resistance and higher blood sugar, tends to show up more strongly in some racial and ethnic groups, while the tools doctors use to score things like excess hair growth weren’t built with every skin tone and hair type in mind, so mild symptoms can be missed or read differently. None of this changes what PMOS is or how it’s treated. It just means the first sign your doctor notices might not be the first sign you noticed.
What causes PMOS?
PMOS develops when an inherited tendency meets other influences: hormone exposure before birth, body chemistry, environment. It is polygenic; many genes each add a small amount of risk, which is why it clusters in families without appearing in every member. Clinicians are advised to factor family history into a diagnosis.8
Insulin resistance and compensatory hyperinsulinemia
This is the central metabolic engine of PMOS, present in most patients including many who are not overweight.10 As cells start to respond sluggishly, the pancreas makes more insulin (the hormone responsible for controlling your blood sugar level); blood sugar can look perfectly normal while insulin quietly runs high for years.
That excess insulin does two things at once. Alongside LH, it pushes theca cells in your ovaries to make more androgens, and it suppresses your liver’s production of sex hormone-binding globulin (SHBG), the protein that holds testosterone inactive.10 Less SHBG means more free testosterone acting on skin, hair follicles, and ovaries, even when total testosterone looks unremarkable, which is why checking only total testosterone misses the picture. Androgens in turn worsen insulin resistance, a self-sustaining cycle.1011
Hyperandrogenism and androgen pathways
“Hyperandrogenism” means androgen levels higher than typical for a woman: total and free testosterone (the latter often reported as the Free Androgen Index), androstenedione, and DHEAS. DHEAS comes from the adrenal glands rather than the ovaries, which is why some women have a mainly adrenal pattern, and insulin drives adrenal androgen production too.10
HPO axis dysfunction and disrupted ovulation
The hypothalamus (the part of your brain that controls all the hormones in your body; think hormonal headquarters) releases GnRH (gonadotropin-releasing hormone) in pulses, and the pituitary responds with LH (luteinizing hormone) and FSH (follicle-stimulating hormone). In PMOS, overactive GnRH neurons drive excess LH and reduced FSH.10 Since FSH is what matures a follicle, low FSH means follicles never get the push they need. Elevated androgens plus excess AMH from immature follicles then arrest follicle development, producing both polycystic ovarian morphology and anovulation.10 Without ovulation, there is no progesterone, and the period does not arrive on schedule.
Inflammation and gut health
C-reactive protein (CRP) is consistently elevated in PMOS; a meta-analysis (it is the study with the strongest scientific evidence) found it roughly 96% higher than in controls, independent of body weight.12 The cytokines usually named alongside it are less certain: the same meta-analysis found no significant difference in IL-6 or TNF-alpha, and a 2025 review concluded the serum evidence does not establish chronic systemic inflammation.13 CRP is the reliable marker; calling PMOS “an inflammatory disease” overstates what is known.
Gut microbiome research follows the same pattern. Reduced bacterial diversity has been reported, but findings are inconsistent and whether dysbiosis drives PMOS or results from it is unresolved.1415 A research frontier, not a reason to buy gut protocols.
Adipose tissue and environment
Fat tissue is an active hormone-producing organ, not inert storage. Obesity is linked to increased insulin resistance and hyperinsulinemia, which worsen androgen excess16; adiponectin and leptin are among the markers studied.12 Endocrine disruptors such as bisphenols and phthalates, shift work, and sustained stress are studied as modifiers, but none was established as a cause.4
What are the risk factors for PMOS?
- Family history is the strongest known risk factor. A mother or sister with PMOS raises your risk substantially, and a family history of type 2 diabetes or metabolic syndrome matters too. Clinicians are advised to weigh it when diagnosing ,8 so mention it even if your symptoms seem mild.
- Baseline metabolic vulnerability: Prediabetes, impaired glucose tolerance, or past gestational diabetes all signal lower insulin sensitivity to begin with.
- Where fat is stored, more than how much. Visceral fat amplifies insulin resistance and therefore symptoms. But this is amplification, not causation. PMOS occurs across the full range of body sizes, and a normal BMI does not rule it out.4
- Environmental modifiers: Endocrine disruptors, night-shift and sleep disruption, and severe long-term stress worsen how PMOS behaves. Contributors, not origins.
Can you develop PMOS at a normal weight (lean PMOS)?
Yes. Lean PMOS looks the same on the outside: irregular cycles, hirsutism, and acne, but adrenal androgens like DHEAS often play a larger role, and insulin signaling problems are subtler. Insulin resistance is present in most patients, including many who are not overweight, which is exactly why a normal weight is not reassuring.10 Lean PMOS is frequently diagnosed late, because the stereotype of who “looks like” they have PMOS gets in the way.
Causation vs triggering
Nothing you ate, no weight you gained, and no stress you failed to manage caused your PMOS. The groundwork was laid long before any of that. Lifestyle factors just triggered it. That is empowering, because it means change helps. It is not the same as blame.
What are the signs and symptoms of PMOS?
Menstrual and ovulatory
- Oligomenorrhea: Periods more than 38 days apart,29 or fewer than about eight a year.3
- Amenorrhea: No period for three months or more.
- Anovulatory cycles: Bleeding without true ovulation.
- Heavy or prolonged bleeding: Without progesterone, nothing tells the lining to stop thickening and shed cleanly. Estrogen keeps building it, so when it finally breaks down, the bleed can be sudden, heavy, and prolonged.
Signs of high androgens
- Hirsutism: Coarse, dark hair in a male pattern; upper lip, chin, jawline, chest, lower abdomen, lower back, inner thighs.
- Acne and oily skin: Deep, tender, cystic breakouts along the jawline, chin, and neck that persist past the teenage years and often shrug off over-the-counter treatments.
- Androgenic alopecia: Thinning at the crown and a widening part, with the frontal hairline usually preserved. Different from hair falling out in patches.34
Metabolic and skin changes
- Acanthosis nigricans: Velvety, darkened skin where areas fold or rub — neck, armpits, groin. A visible marker of high insulin, often mistaken for poor hygiene, which it is not.
- Skin tags: Small, soft growths in the same areas.
- Weight difficulty, particularly around the abdomen, despite sustained effort.4
Mood, sleep, and cognition
Anxiety, low mood, severe premenstrual mood changes, disrupted sleep, and “brain fog” are common and increasingly recognized as core features; the 2023 guideline flagged their very high prevalence.35
Can you have PMOS without obvious symptoms?
Yes. Some women have androgen elevation detectable only on blood tests, with no visible hair or skin changes. Others have polycystic ovarian morphology found by chance on a scan done for another reason, which alone is not a diagnosis.35
PMOS through the lifespan
- Adolescence: Diagnosis is difficult because irregular cycles are normal in the first couple of years after a first period, and a healthy adolescent ovary often holds many follicles. To avoid overdiagnosing normal puberty, guidelines require both ovulatory dysfunction and hyperandrogenism in teenagers, and recommend against ultrasound or AMH at this age.35 A teenager with concerning features who does not meet criteria can be labeled “at risk” and reassessed.
- Reproductive years: Usually when PMOS is diagnosed, management is most active balancing cycle regulation, endometrial protection, contraception, skin and hair symptoms, fertility planning, and metabolic screening. Priorities shift over time, and treatment should shift with them.
- Pregnancy: Common and usually goes well, but higher risk. Guidelines recognize elevated risk of gestational diabetes, pregnancy-related high blood pressure, preeclampsia, and preterm birth.35 Optimize metabolic health before conception, not after a positive test.
- Postpartum: Symptoms can return once your hormones shift back after delivery, so don’t be alarmed if acne or irregular cycles return. Metformin is generally considered compatible with breastfeeding, with caution advised for newborns and premature infants.9 And since postpartum depression risk is already higher with PMOS,28 it’s important that you mention your history to your doctor so they’re watching your mood, not just your body.
- Perimenopause: Counterintuitively, as ovarian reserve declines, cycles often become more regular. This can feel like the condition is resolving. Reproductive symptoms ease while metabolic risks become more prominent.
- After menopause: The ovulation problem becomes irrelevant, but metabolic and cardiovascular vulnerability does not. This is a chronic metabolic condition that persists beyond the reproductive years,8 so screening for blood pressure, lipids, and blood sugar should continue.35
How is PMOS diagnosed?
There is no single test. NICHD, the NIH’s child health institute, describes the same approach: most diagnostic schemes require two of three features.17
The 2026 name change did not change how PMOS is diagnosed. The criteria are the Rotterdam criteria, reaffirmed in the 2023 International Evidence-Based Guideline.5 In adults, diagnosis requires two of the following three, after excluding other causes35:
| # | Criterion | What it means |
| 1 | Ovulatory dysfunction | Irregular, infrequent, or absent periods |
| 2 | Hyperandrogenism | Visible signs (hirsutism, acne, hair thinning) or elevated androgens on blood tests |
| 3 | Polycystic ovarian morphology | Seen on ultrasound or, in adults only, an elevated AMH level |
If you have both irregular cycles and hyperandrogenism, you already meet criteria, and no ultrasound or AMH test is needed.35 In adolescents, criteria 1 and 2 are both required and criterion 3 is not used at all.
Blood panels
| Purpose | Tests |
| Androgens | Total testosterone, free testosterone or Free Androgen Index, DHEAS, androstenedione |
| Pituitary/ovarian | LH, FSH, AMH |
| Metabolic | Fasting glucose, HbA1c, oral glucose tolerance test (OGTT), fasting insulin, lipid panel |
| Ruling out mimics | TSH (thyroid), prolactin, 17-hydroxyprogesterone |
The last row is not optional, as those tests catch conditions that imitate PMOS and are treated completely differently.
What is the role of serum AMH and an ultrasound in PMOS?
On transvaginal ultrasound, polycystic ovarian morphology means 20 or more follicles measuring 2-9 mm in at least one ovary, or an ovarian volume of 10 mL or more.18 With abdominal ultrasound, ovarian volume is preferred. The 2023 guideline added serum AMH as an alternative in adults, because it closely tracks follicle count and is easier and cheaper in primary care.1819 Neither should be used within 8 years of a first period.
You do not need “ovarian cysts” to have PMOS. Irregular cycles plus androgen excess meet the criteria regardless of what your ovaries look like. A normal ultrasound does not rule out PMOS.7
What are the complications and long-term risks of PMOS?
Major U.S. medical centers summarize the long-term risks as higher rates of type 2 diabetes, high blood pressure, heart problems, and endometrial cancer.17 None is inevitable, and most are substantially reducible with monitoring and treatment.
Prediabetes and type 2 diabetes: Long-standing insulin resistance forces the pancreas to overwork, and over years the insulin-producing cells tire. Screen with OGTT or HbA1c at diagnosis, repeated periodically. Manage with nutrition and activity changes, metformin, and sometimes GLP-1 receptor agonists.4
Fatty liver disease (MASLD): High insulin drives the liver to make and store fat. A meta-analysis of 36 studies found fatty liver disease in roughly 4 in 10 women with the condition (43%, 95% CI 35–52%), with higher risk in those with hyperandrogenism.20 Screen with liver enzymes (ALT, AST), adding ultrasound or FibroScan if abnormal. Managed through metabolic control and dietary change.
High cholesterol: Insulin resistance shifts the lipid profile toward higher triglycerides, lower HDL, and smaller, denser LDL particles. ACOG has long recommended a fasting lipid panel for all women with this diagnosis.21 Managed with dietary change, exercise, and statins where indicated.
Cardiovascular disease and hypertension: Inflammation and insulin resistance affect the lining of blood vessels, contributing to stiffer arteries and higher blood pressure over time. Blood pressure at every visit, plus periodic cardiovascular risk assessment.
Endometrial hyperplasia and cancer: The most preventable serious risk in PMOS. Without progesterone, the lining is exposed to estrogen continuously with nothing to clear it; over years it can overgrow and, in a minority of cases, progress toward cancer. Transvaginal ultrasound for unexplained bleeding or gaps longer than about 90 days. Managed by making the lining shed regularly with cyclic progestogens, combined oral contraceptives, or a levonorgestrel IUD. Regulating your cycle is not cosmetic; it is cancer prevention.
Infertility: Caused by unpredictable ovulation, not an absence of eggs. Get assessed early if your cycles are very irregular or you are over 35. Managed with letrozole, preconception metabolic optimization, and assisted reproduction if needed.
Depression and anxiety: Driven by hormonal effects, inflammation, and the burden of a chronic, visible condition. Rates are markedly elevated, which is why the 2023 guideline made psychological screening a core recommendation.35 An overlap with ADHD and autism is under investigation, emerging, not settled. Screen with the PHQ-9 (Patient Health Questionnaire-9) and GAD-7 (Generalized Anxiety Disorder-7); manage with CBT and psychiatric care where appropriate.
Eating disorders: Rates of binge eating and disordered eating are higher here, and years of weight-focused advice can make things worse. Your clinician should ask about your relationship with food before recommending any structured eating plan. If any advice in this article or from anyone else is triggering restriction, bingeing, or distress around food, that is a signal to seek support, not to try harder.3
Obstructive sleep apnea: Androgens affect upper airway stability, and the increased risk exists partly independent of body weight. Screen with a STOP-Bang questionnaire, then a sleep study if indicated. Treated with CPAP, which often improves daytime energy and insulin sensitivity together.3
How helpful is lifestyle and self-care?
Lifestyle change is first-line therapy in international guidelines and works alongside, not instead of, medical treatment ,35 and it works partly through mechanisms unrelated to weight loss.
Eating
According to the international guidelines, no single “PMOS diet” has been proven superior to the other.3 However, a balanced diet includes fiber-rich carbohydrates that release sugar slowly, adequate protein, plenty of vegetables, and healthy fats including omega-3s. A Mediterranean-style pattern fits well and is easy to sustain. Extreme restriction and elimination protocols carry elevated risk given how common disordered eating already is in this population, so should be avoided.
Movement
Exercise improves insulin sensitivity even if your weight does not change; the effects appear independent of weight loss.22 One of the most useful facts in this guide.
- Aerobic activity: Guidelines point to roughly 150 minutes of moderate or 75 minutes of vigorous activity per week.323
- Resistance training: Building muscle increases the tissue available to absorb glucose; meta-analysis found improvements in insulin resistance and free androgen index.24 One caveat: a network meta-analysis ranked yoga and high-intensity interval training ahead of resistance training here.24
- Less sitting: Breaking up long stretches of sitting helps independent of formal exercise.
Sleep and stress
Poor sleep worsens insulin resistance and disrupts the hunger hormones ghrelin and leptin. Consistent sleep and wake times, morning daylight, a dark, cool bedroom, and fewer screens before bed all help. If you snore, gasp, or wake unrefreshed, ask about a sleep study; untreated apnea undermines everything else.
Chronic stress raises cortisol and can nudge adrenal androgen production upward. Mindfulness, yoga, breathwork, and genuine rest are not indulgences here; they act on a system measurably part of this condition. Yoga in particular performed well for insulin resistance in a head-to-head comparison of exercise types.24
What are the medical treatments for PMOS?
Treatment is chosen around your goals. There is no universal first-line drug; the right starting point depends on whether your priority is cycle regulation, skin and hair, metabolic health, or pregnancy.
| Treatment | Best for | Key considerations |
| Combined oral contraceptives | Cycle regulation, acne, hirsutism, endometrial protection | Not suitable if trying to conceive; blood pressure and clot risk reviewed first |
| Cyclic progestogens / LNG-IUD | Endometrial protection without estrogen | Does not treat acne or hair symptoms |
| Metformin | Insulin resistance, metabolic risk | GI side effects; monitor vitamin B12 long term |
| Anti-androgens | Hirsutism, hair thinning, resistant acne | Reliable contraception is mandatory |
| Letrozole | Ovulation induction | Used only when trying to conceive |
- Combined oral contraceptives remain first-line for most women whose main concerns are irregular cycles, acne, or unwanted hair growth and who are not trying to conceive.421
- Progestogen therapy: If you cannot take estrogen or do not want it, cyclic oral progestogens such as medroxyprogesterone, taken for part of each cycle or every few months as prescribed, trigger the lining to shed.21 A levonorgestrel IUD protects the endometrium continuously and often reduces bleeding significantly.
- Metformin lowers the glucose your liver releases and improves how tissues respond to insulin. Lower insulin means less ovarian androgen production, which is why some women see cycles become more regular on it.34
- Anti-androgens: Spironolactone is the most commonly used in the U.S., blocking androgen receptors in skin and hair follicles. All anti-androgens can harm a developing male fetus, so reliable contraception is non-negotiable. Eflornithine cream slows facial hair regrowth and is used alongside. Expect three to six months before judging results.
- Skin and hair procedures: Topical retinoids and benzoyl peroxide for acne, laser or electrolysis for hirsutism. Laser works best on dark hair and is far more effective when androgens are medically controlled at the same time.
- Bariatric surgery: For women with PMOS and severe obesity, weight-loss surgery is a real option once lifestyle changes and medication fail. It can improve insulin resistance and restore ovulation. But it’s a big decision with its own risks, and you need to wait a while before trying to conceive afterward. It’s usually only discussed after other options have been tried.3
What are the new treatments for PMOS?
Inositol
Inositols relay insulin and FSH signals inside cells. Most research uses a specific combination of two inositol forms,25 and a systematic review informed the 2023 guideline.26 Reported benefits are better insulin sensitivity and more frequent ovulation, with mild side effects. As the evidence is weaker than metformin’s and the quality varies, it should be discussed with your doctor rather than used in place of prescribed treatment.
NAC and berberine
N-acetylcysteine (NAC) is an antioxidant. Small studies show it may help with insulin sensitivity and ovulation. Berberine is a plant compound. A few trials found it works similarly to metformin for some metabolic markers. Neither replaces proper treatment. Check with your doctor before starting either one, especially if you’re on other medications.
GLP-1 and dual GIP/GLP-1 receptor agonists
These drugs reduce appetite, visceral fat, and body weight, and many women report more regular cycles. But a 2026 meta-analysis of 11 randomized trials found a clear BMI reduction while concluding the evidence was insufficient on menstrual regularity, hirsutism, glucose, or insulin, with no trials of these two drugs specifically in this population.27
- Approved for obesity and type 2 diabetes; use for PMOS alone is off-label.
- Fertility can return unexpectedly, so reliable contraception is essential.
- These medications must be stopped before trying to conceive; your doctor will tell you how far in advance, which differs by drug.27
- Tirzepatide can reduce oral contraceptive effectiveness around starting and dose increases; non-oral methods such as the IUD or implant are not affected.6
Statins and microbiome therapies
Statins address cholesterol and cardiovascular risk in PMOS as in anyone else, but are not a PMOS treatment in their own right and are avoided in pregnancy.21 Probiotics, new insulin sensitizers, and anti-inflammatory agents are under investigation,15 but no specific product is yet supported.
PMOS and fertility
PMOS is a problem of egg release, not egg supply; ovarian reserve is typically high, which is why AMH tends to be elevated.18 Ovulation happens unpredictably or not at all, making this the most common cause of anovulation worldwide.8
Many women conceive naturally, spontaneously in some cycles or after regaining ovulation through metabolic improvement, metformin, or inositol. One pitfall if you track: ovulation predictor kits detect LH, which is often already elevated in PMOS, giving repeated false positives.3 Basal body temperature, cervical mucus, or a mid-luteal progesterone test are more reliable.
Before trying: Start a prenatal vitamin with folic acid, work on blood sugar control, review medications with your doctor (anti-androgens, statins, and GLP-1 drugs all need to be stopped), and check blood pressure and thyroid function; guidelines recommend addressing these before pregnancy, not after.35
Ovulation induction: Letrozole is first-line, producing higher ovulation and live birth rates than clomiphene; ACOG updated its guidance to reflect this.21 Clomiphene remains an alternative, metformin is sometimes added when response is poor, and gonadotropins are second-line, needing ultrasound monitoring to limit multiples and ovarian hyperstimulation syndrome (OHSS). For resistant cases, ovarian drilling and IVF both work well, and freeze-all GnRH antagonist protocols have substantially cut OHSS risk.
When to see a specialist: After 12 months of trying if you are under 35, or 6 months if 35 or older. But if your cycles are markedly irregular or absent, do not wait, as you cannot conceive in a cycle in which you don’t ovulate.
How can you manage your symptoms day-to-day?
- Track your cycle and symptoms: An app or notebook recording period dates, flow, acne flares, mood, and energy gives your doctor better information than memory does, and diagnosis depends on documenting cycle irregularity over time.35
- Build meals by addition: Protein, fiber, vegetables, healthy fats. More sustainable and psychologically safer than subtraction.
- Move in ways you will repeat: The best exercise is the one that fits your week. Consistency beats intensity.
- Protect your sleep: Consistent timing, a dark room, a real wind-down routine. Sleep is a metabolic intervention.
- Stay consistent with medications: Acne treatments take 8–12 weeks and hair treatments 3–6 months before you can fairly judge them. Most are abandoned too early.
- Care for skin and hair gently: Non-comedogenic products, no harsh scrubbing, loose styles and minimal heat for thinning hair.
- Protect your mental health: Find a support community, PCOS Challenge: The National Polycystic Ovary Syndrome Association is a good place to start. Set boundaries around unsolicited advice about your body, and treat psychological support as part of your medical care; screening for anxiety and depression is now a formal guideline recommendation.35
- Keep a screening calendar: Annual blood pressure, periodic glucose and lipid panels,21 and a note of how long it has been since your last period; anything approaching 90 days warrants a call.
- Be skeptical of miracle cures: Detox teas, protocols promising to “reverse” PMOS, and social-media supplement bundles are at best expensive. Any claim to cure a lifelong condition is false; no cure exists, and PMOS persists beyond the reproductive years.8
Can PMOS be prevented?
No, and it is important to say so honestly. The exact cause is still unknown, and most experts consider genetics a major contributor.4 No health body publishes a strategy for preventing PMOS itself, because none exists. Anyone selling prevention is selling something else.
The complications are a different story. Guidelines frame PMOS care around a lifelong health plan aimed precisely at heading off downstream risks,35 and early, consistent management can meaningfully reduce or prevent:
- Progression from prediabetes to type 2 diabetes
- Significant cholesterol abnormalities and early cardiovascular disease
- Endometrial hyperplasia and cancer, largely preventable through cycle regulation
- Severe hirsutism and advanced hair loss, which respond far better to early treatment
- Long-term metabolic decline
You cannot change whether you have PMOS. You can change almost everything about where it takes you.
What is living with PMOS like?
- Unpredictable cycles: A particular exhaustion in never knowing whether a period will arrive this month or in four, and in explaining again that no, you are not pregnant.
- Skin and hair changes: Facial hair, persistent acne, and thinning hair carry a psychological weight clinicians underestimate. The daily time spent on removal and concealment is real, and so is the anxiety about being seen without it. These are legitimate medical symptoms, not vanity concerns.
- Body image and weight stigma: Many women describe going to a doctor about missed periods and being told to lose weight, without any testing. Delayed diagnosis and patient dissatisfaction with care are well documented and were among the stated reasons for changing the name. You are entitled to ask: “What tests will you run, and what would we do if my weight were normal?”
- Fertility anxiety: The worry often starts long before you are ready to have children, sometimes in your teens.
- Mood and relationships: Hormonal shifts, fatigue, and the management burden affect mood, intimacy, and patience with those closest to you.14
- Work and school: Sudden heavy bleeding, fatigue, and brain fog make consistency harder. Practical accommodations such as supplies at your desk and flexibility on heavy days are reasonable to arrange.
- Cost and coverage: Blood work, an ultrasound, and a regular doctor visit are usually covered like any other diagnostic test. Costs tend to increase with specialist visits. Some medications aren’t approved specifically for PMOS, so insurance may not cover them. Hair removal is almost never covered. If cost feels like a lot, ask your doctor’s office about generic options or a payment plan. Don’t assume something is out of reach before you ask.
Why “just lose weight” is inadequate advice: Not that weight is irrelevant, but this response treats a multisystem endocrine condition as a willpower problem, skips the workup, ignores lean patients, and leaves the drivers untouched. Correcting this pattern was among the stated reasons for the renaming.12
What should you ask your doctor?
Here are some of the questions you should be asking your doctor at a regular appointment to manage and understand your condition better:
Diagnosis
- Which criteria do I meet, and what else have you ruled out — thyroid, prolactin, adrenal?
- Do I need androgen blood tests, fasting insulin, or an OGTT?
- Do I need an ultrasound, or do I already meet criteria without one?
Long-term health
- What are my current glucose and lipid results, and what do they mean?
- How often should blood pressure, glucose, and lipids be rechecked?
Treatment
- Which treatment fits my main goal: uterine lining, hair growth, acne, or metabolic health?
- Would metformin, inositol, or a GLP-1 medication help me specifically, and what are the trade-offs?
- What side effects should I expect, and how long before I can judge if it is working?
Fertility
- How do my current treatments fit with my plans for children?
- What should I do before trying to conceive, and which medications must I stop first?
- At what point should we consider letrozole or a fertility referral?
Wider support
- Can you refer me to a dietitian who works in a non-restrictive way?
- Should I be screened for sleep apnea or fatty liver disease?
- What mental health support do you recommend?
When to see a doctor?
Book an appointment with your OB-GYN if you notice:
- Cycles consistently longer than 38 days or shorter than 24 days.29
- No period for more than 90 days when not pregnant, and prolonged gaps expose the lining to unopposed estrogen.35
- Rapidly worsening facial or body hair, a deepening voice, or sudden significant hair loss; rapid onset warrants evaluation for other causes of androgen excess.
- Difficulty conceiving after 12 months of trying, or 6 months if you are 35 or older.
- Excessive thirst, frequent urination, unexplained fatigue, blurred vision; diabetes risk is elevated in PMOS, often at a younger age.34
- Loud snoring, gasping in your sleep, or persistent daytime sleepiness.
- Persistent low mood, anxiety, or distress affecting daily life.35
- Any vaginal bleeding after menopause, which always needs evaluation.
Seek immediate medical care for:
- You are soaking through one or more pads or tampons every hour for more than two hours in a row.21
- You have sudden, severe pelvic pain, which needs urgent evaluation for ovarian torsion, a ruptured cyst, or ectopic pregnancy.4
- You have chest pain, sudden shortness of breath, or one-sided leg swelling, especially if you take estrogen-containing contraception.21
Frequently asked questions
PMOS is the updated international name for PCOS; a lifelong condition involving hormone imbalance, insulin resistance, and irregular ovulation.
Yes. Only the name changed, announced in The Lancet on May 12, 2026, to reflect its multisystem nature.
“Polycystic” was inaccurate, as those are immature follicles, not cysts, and the old name framed a whole-body condition as purely gynecological.
No. The 2026 change was to the name only. Diagnosis still follows the 2023 International Evidence-Based Guideline criteria.
By meeting two of three criteria: irregular ovulation, androgen excess, and polycystic ovaries on ultrasound or high AMH, after ruling out other conditions.
Yes. Irregular cycles plus androgen excess is enough on its own. An ultrasound can show immature follicles, but it is not required for diagnosis.
Yes. “Lean PMOS” affects women at a normal weight, often with more adrenal androgen involvement and subtler insulin problems.
Irregular periods in adolescence, persistent jawline acne, excess facial or body hair, central weight gain, or dark velvety neck patches.
It is a leading cause of ovulatory infertility, but most women with PMOS who want children have them. Many ovulate spontaneously in some cycles or regain regular ovulation with lifestyle changes, metformin, or inositol.
Yes. Diabetes risk is significantly elevated, often at a younger age, and PMOS raises cardiovascular risk factors including high blood pressure and abnormal cholesterol, which is why regular screening matters.
They reduce weight and improve metabolic markers, but a 2026 meta-analysis found the evidence insufficient to confirm an effect on menstrual regularity. They are approved for obesity and diabetes rather than PMOS, and must be stopped before trying to conceive.
Yes. Cycle symptoms end, but metabolic and cardiovascular risks persist for life.
No cure, because it is a lifelong metabolic trait. But symptoms can be well controlled and most long-term risks substantially reduced.
Last medically reviewed on
References
Our commitment to accuracy is paramount; we use high-quality sources, including peer-reviewed studies, to support the facts in our articles. Learn more about our Editorial Process.
- Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329–2339. doi:10.1016/S0140-6736(26)00717-8. pubmed.ncbi.nlm.nih.gov
- Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. May 12, 2026. endocrine.org
- Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469. doi:10.1210/clinem/dgad463. academic.oup.com
- U.S. Department of Health and Human Services, Office on Women's Health. Polycystic ovary syndrome. womenshealth.gov
- American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome. 2023. asrm.org
- U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2025. accessdata.fda.gov
- Cleveland Clinic. PMOS (Polyendocrine Metabolic Ovarian Syndrome): Symptoms & Treatment. my.clevelandclinic.org
- World Health Organization. Polycystic ovary syndrome. Fact sheet. who.int
- National Library of Medicine. Metformin. In: Drugs and Lactation Database (LactMed). Last revised July 15, 2026. ncbi.nlm.nih.gov
- Houston EJ, Templeman NM. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. J Endocrinol. 2025;265(2):e240269. doi:10.1530/JOE-24-0269. pmc.ncbi.nlm.nih.gov
- Szkodziak P, Szkodziak F, Trzeciak K, et al. Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology. Sci Rep. 2025;15:42649. doi:10.1038/s41598-025-26718-2. nature.com
- Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):1048–1058.e2. doi:10.1016/j.fertnstert.2010.11.036. fertstert.org
- De Robles G, Wiggins KD, Del Mundo Z, Ujagar N, Nguyen CM, Seldin MM, Pacheco-Sanchez G, Nicholas DA. Unpacking PCOS Inflammation: From Misconceptions to Immune Networks. Endocrinology. 2025;166(12):bqaf166. doi:10.1210/endocr/bqaf166. academic.oup.com
- Li P, Shuai P, Shen S, et al. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Med. 2023;21(1):302. doi:10.1186/s12916-023-02975-8. link.springer.com
- Elhennawy F, Naji B, Butler AE. The gut microbiome in polycystic ovary syndrome: mechanistic pathways and therapeutic potential of microbiota-targeted interventions. Front Endocrinol. 2026;17:1900535. doi:10.3389/fendo.2026.1900535. frontiersin.org
- Balogh Z, Csehely S, Orosz M, et al. Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients. Biomedicines. 2025;13(8):1803. doi:10.3390/biomedicines13081803 ncbi.nlm.nih.gov
- Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. Polycystic Ovary Syndrome (PCOS). nichd.nih.gov
- Piltonen TT, Viita-Aho J, Saarela U, Melin J, Forslund M. Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis. Semin Reprod Med. 2024;42(1):49–59. doi:10.1055/s-0044-1786731. pmc.ncbi.nlm.nih.gov
- van der Ham K, Laven JSE, Tay CT, Mousa A, Teede H, Louwers YV. Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. Fertil Steril. 2024;122(4):727–739. doi:10.1016/j.fertnstert.2024.05.163. fertstert.org
- Manzano-Núñez R, Santana-Domínguez M, Rivera-Esteban J, et al. Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression. J Clin Med. 2023;12(3):856. doi:10.3390/jcm12030856. pubmed.ncbi.nlm.nih.gov
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131:e157–e171. acog.org
- Exercise and Sports Science Australia. Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia. J Sci Med Sport. 2024;27(10):668–677. doi:10.1016/j.jsams.2024.05.015. sciencedirect.com
- Patten RK, Boyle RA, Moholdt T, et al. Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Physiol. 2020;11:606. doi:10.3389/fphys.2020.00606. frontiersin.org
- Tan Y, Liu Y, Koga A, Yuan Y, Yu H, Liu J. The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study. Healthcare (Basel). 2025;13(17):2132. doi:10.3390/healthcare13172132. pmc.ncbi.nlm.nih.gov
- Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512–5521. doi:10.26355/eurrev_201906_18132. pubmed.ncbi.nlm.nih.gov
- Fitz V, Graca S, Mahalingaiah S, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630–1655. doi:10.1210/clinem/dgad762. academic.oup.com
- Forslund M, Wändell P, Forsberg L, et al. GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis. Eur J Endocrinol. 2026;194(3):S25–S39. doi:10.1093/ejendo/lvag033. academic.oup.com
- Koric A, Singh B, VanDerslice JA, et al. Polycystic ovary syndrome and postpartum depression symptoms: a population-based cohort study. Am J Obstet Gynecol. 2021;224(6):591.e1–591.e12. doi:10.1016/j.ajog.2020.12.1215. pubmed.ncbi.nlm.nih.gov
- Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. doi:10.1002/ijgo.12666. pubmed.ncbi.nlm.nih.gov
Update history
Our team monitors the health and wellness space to keep articles current.
Current version (September 21, 2026) — Medically reviewed by Dr. Sara Ahmad Qureshi, MBBS, MS. Written by Dr. Ghanwa Imran, MBBS.





